• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

术前识别卵巢和子宫内膜同步癌:适当检查的重要性。

Preoperative identification of synchronous ovarian and endometrial cancers: the importance of appropriate workup.

机构信息

Department of Obstetrics and Gynaecology, St Elisabeth Hospital, Tilburg, The Netherlands.

出版信息

Int J Gynecol Cancer. 2012 Oct;22(8):1325-31. doi: 10.1097/IGC.0b013e3182679119.

DOI:10.1097/IGC.0b013e3182679119
PMID:22968517
Abstract

OBJECTIVE

For treatment of patients with both endometrial and ovarian cancer, it is important to discriminate between 2 primary tumors and metastatic disease. Currently, criteria are based on postoperative findings. The aim of this study was to determine whether clinical parameters can discriminate between these groups preoperatively and whether a practical guideline could improve appropriate workup and treatment.

METHODS

A total of 45 patients with a diagnosis of both endometrium and ovarian cancer between 1998 and 2009 and were included for analysis. Clinical and pathological data were obtained, and initial CA-125 was registered; patients had a diagnosis of 2 primary tumors or tumors with metastasis. All patients were reclassified according to workup and treatment.

RESULTS

Patients with synchronous primary tumors were significantly younger, presented more often with abnormal uterine bleeding, and had a lower initial CA-125 than both metastatic groups (P < 0.05). With age and CA-125 included in a polytomic logistic regression model, 83.3% of diagnoses could be classified correctly. In 15 of 17 patients presented with adnexal mass, workup was incomplete owing to lack on information of the endometrial status. In patients presenting with abnormal uterine bleeding, 13 of 21 patients had an incomplete workup leading to staging laparotomy secondary to initial surgical treatment in 2 patients.

CONCLUSIONS

Patients with synchronous endometrial and ovarian cancers are young, often present with abnormal uterine bleeding and have a low initial CA-125. Adequate workup with attention to both ovarian and endometrial status, especially in young patients with a wish to preserve fertility, is important to make the right decision for treatment.

摘要

目的

对于同时患有子宫内膜癌和卵巢癌的患者,区分两种原发性肿瘤和转移性疾病非常重要。目前,标准基于术后发现。本研究旨在确定临床参数是否可以在术前区分这些组,以及是否可以制定实用的指南来改善适当的检查和治疗。

方法

本研究共纳入了 1998 年至 2009 年间诊断为子宫内膜和卵巢癌的 45 例患者进行分析。收集了临床和病理数据,并记录了初始 CA-125;患者被诊断为两种原发性肿瘤或有转移的肿瘤。所有患者均根据检查和治疗进行重新分类。

结果

同步原发性肿瘤患者明显更年轻,常出现异常子宫出血,且初始 CA-125 低于两种转移组(P<0.05)。在包含年龄和 CA-125 的多元逻辑回归模型中,83.3%的诊断可以正确分类。在 17 例表现为附件包块的患者中,由于缺乏子宫内膜状态的信息,检查并不完整。在表现为异常子宫出血的 21 例患者中,有 13 例检查不完整,导致 2 例患者因初始手术治疗而进行分期腹腔镜检查。

结论

患有同步子宫内膜癌和卵巢癌的患者年轻,常出现异常子宫出血,且初始 CA-125 较低。充分的检查,注意卵巢和子宫内膜的状态,尤其是在有生育愿望的年轻患者中,对于做出正确的治疗决策非常重要。

相似文献

1
Preoperative identification of synchronous ovarian and endometrial cancers: the importance of appropriate workup.术前识别卵巢和子宫内膜同步癌:适当检查的重要性。
Int J Gynecol Cancer. 2012 Oct;22(8):1325-31. doi: 10.1097/IGC.0b013e3182679119.
2
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.拓扑替康治疗卵巢癌的临床有效性和成本效益的快速系统评价。
Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280.
3
Are Current Survival Prediction Tools Useful When Treating Subsequent Skeletal-related Events From Bone Metastases?当前的生存预测工具在治疗骨转移后的骨骼相关事件时有用吗?
Clin Orthop Relat Res. 2024 Sep 1;482(9):1710-1721. doi: 10.1097/CORR.0000000000003030. Epub 2024 Mar 22.
4
Taxane monotherapy regimens for the treatment of recurrent epithelial ovarian cancer.紫杉烷类单药治疗方案用于复发性上皮性卵巢癌。
Cochrane Database Syst Rev. 2022 Jul 12;7(7):CD008766. doi: 10.1002/14651858.CD008766.pub3.
5
Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.两种现代生存预测工具 SORG-MLA 和 METSSS 在接受手术联合放疗和单纯放疗治疗有症状长骨转移患者中的比较。
Clin Orthop Relat Res. 2024 Dec 1;482(12):2193-2208. doi: 10.1097/CORR.0000000000003185. Epub 2024 Jul 23.
6
Concurrent endometrial intraepithelial carcinoma (EIC) and serous ovarian cancer: can EIC be seen as the precursor lesion?同时性子宫内膜上皮内癌(EIC)和浆液性卵巢癌:EIC 能否被视为前驱病变?
Int J Gynecol Cancer. 2012 Mar;22(3):457-64. doi: 10.1097/IGC.0b013e3182434a81.
7
Intraoperative frozen section analysis for the diagnosis of early stage ovarian cancer in suspicious pelvic masses.术中冰冻切片分析用于诊断可疑盆腔肿块中的早期卵巢癌。
Cochrane Database Syst Rev. 2016 Mar 1;3(3):CD010360. doi: 10.1002/14651858.CD010360.pub2.
8
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
9
Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.原发性手术后晚期上皮性卵巢癌患者残留病灶对生存预后的影响。
Cochrane Database Syst Rev. 2022 Sep 26;9(9):CD015048. doi: 10.1002/14651858.CD015048.pub2.
10
Selective progesterone receptor modulators (SPRMs) for uterine fibroids.用于子宫肌瘤的选择性孕激素受体调节剂(SPRMs)
Cochrane Database Syst Rev. 2017 Apr 26;4(4):CD010770. doi: 10.1002/14651858.CD010770.pub2.

引用本文的文献

1
Uterine involvement in epithelial ovarian cancer and its risk factors.子宫在卵巢上皮性癌中的累及及其危险因素。
J Ovarian Res. 2021 Dec 7;14(1):171. doi: 10.1186/s13048-021-00925-7.
2
Elevated CA-125 Level and ER-Negative as Prognostic Factors for Ovarian Metastasis in Patients with Endometrial Cancer: A Retrospective Cohort Study.CA-125水平升高及雌激素受体阴性作为子宫内膜癌患者卵巢转移的预后因素:一项回顾性队列研究
Med Sci Monit. 2020 Dec 25;26:e928826. doi: 10.12659/MSM.928826.
3
Molecular profiling identifies synchronous endometrial and ovarian cancers as metastatic endometrial cancer with favorable clinical outcome.
分子谱分析将同步性子宫内膜和卵巢癌鉴定为具有良好临床结局的转移性子宫内膜癌。
Int J Cancer. 2020 Jul 15;147(2):478-489. doi: 10.1002/ijc.32907. Epub 2020 Feb 18.
4
Comparison and analysis of the clinicopathological features of SCEO and ECOM.比较和分析 SCEO 和 ECOM 的临床病理特征。
J Ovarian Res. 2019 Jan 30;12(1):10. doi: 10.1186/s13048-019-0485-5.
5
Comparison of clinicopathologic variables in coexistence cancers of the endometrium and ovary: A review of 55 cases in an academic center in Iran.子宫内膜癌与卵巢癌并存的临床病理变量比较:伊朗某学术中心55例病例回顾
J Res Med Sci. 2015 Aug;20(8):727-32. doi: 10.4103/1735-1995.168315.
6
[Morphology of secondary ovarian tumors and metastases].[继发性卵巢肿瘤与转移瘤的形态学]
Pathologe. 2014 Jul;35(4):336-47. doi: 10.1007/s00292-014-1907-1.